Viriom Selects ChemDiv To Develop HIV Program
October 20, 2009 by admin
ChemDiv, Inc. (ChemDiv) of San Diego has proudly announced that its wholly owned subsidiary Chemical Diversity Research Institute (CDRI ) of Moscow, Russia, has been chosen by Viriom Ltd. ( Viriom) of Moscow, Russia as a service partner in developing innovative HIV compounds. The program includes pre-clinical and clinical studies, which are expected to begin in 2010. Viriom has recently signed the license agreement with Roche.
Comments
Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!